SCL · NYSE · Chemicals - Specialty

Stepan (SCL)

Makes surfactants, polyols, resins, and specialty ingredients for manufacturers.

$64.55
vs last close+0.17 (+0.26%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue562532551556547526593595590554605684
Cost of revenue491466481487471469518523519502540584
Gross profit7166707076577572715265100
526650515249475449504958
Research & development141514141414151514161517
353734363836343734343339
Selling & marketing121211121111121511111215
General & administrative232523252625212323242124
Other expenses313201−1−121011
Operating income200201924828182211642
−4−4−1−1−3−5−4−4−54−70−10
Interest income000000000000
Interest expense3233454510056
Other non-operating income−50000100−2−17654
Income before tax16−419172122514175−5433
Income tax expense3−268−2−15260−1310
Net income from continuing operations13−114102432011115−4123
Net income13−114102432011115−4123
EPS, basic$0.55−$0.05$0.61$0.42$1.03$0.15$0.86$0.50$0.47$0.22−$1.81$1.00
EPS, diluted$0.55−$0.05$0.61$0.42$1.03$0.15$0.86$0.50$0.47$0.22−$1.81$1.00
Weighted average shares, basic232323232323232323232323
Weighted average shares, diluted232323232323232323232323
EBITDA51274847523658505651−1669
Depreciation & amortization262728282829293133333331
EBIT250211924729182318−4938